OCON Medical was founded by the IUB™‘s inventor Dr. Ilan Baram, MD, a senior gynecologist specializing in contraception and currently OCON‘s Medical Director.

Serving as OCON‘s CEO, Ariel Weinstein has 20 years of experience in the clinical and medical device development fields, holding leadership positions since 2006.

OCON‘s CFO is Amir Avraham, CPA, who was until recently at Secure Islands, a company acquired by Microsoft, and prior to this was CFO of Van Leer Ventures Jerusalem.

Eran Nir, Ph.D. is our CTO, responsible for R&D and technology aspects, relying on his extensive development and pre-clinical expertise in companies such as J&J and Chiasma Pharma.

Meir Rimer has well over ten years of experience in biomedical companies such as Macrocure and Glycominds and serves as OCON's seasoned Operations Manager.

Our VP QA and Regulatory Affairs is Dr. Yael Klin, PhD who has many years of experience in regulatory and quality assurance work in the pharma and drug-device industries.

The IUB™ Product Manager is Ms. Michal Haham, a corporate and marketing veteran of companies including NeuroDerm Ltd. and Neurim Pharmaceuticals. 

Noa Chachkes is OCON‘s dedicated Administrative Manager and HR Supervisor who has gained substantial experience in the company‘s logistics and administrative roles.

OCON‘s Chairman is Dr. Charles Woler, Ph.D., a present and former pharmaceutical, medical device and VC fund executive in multiple high profile international companies.



Prof. James Trussell - One of the world‘s foremost experts on family planning with particular expertise in contraceptive effectiveness and cost effectiveness. He is Professor of Economics and Public Affairs and Faculty Associate at the Office of Population Research at Princeton University as well as a visiting Professor at The Hull York Medical School with over 300 published peer reviewed papers and numerous professional affiliations.

David Hubacher, Ph.D. - A world renowned expert and key opinion leader on contraceptive methods and IUDs in particular, Dr. Hubacher serves as a senior scientist at Family Health International (FHI360). He has over 25 years research experience, authored dozens of key peer reviewed publications and speaks at conferences worldwide. He received his M.P.H. in Biostatistics and his Ph.D. in Epidemiology from UNC Chapel Hill.

Amos Ber, MD – A senior Ob/Gyn, Dr. Ber has authored over 40 peer reviewed papers and has extensive experience with hormonal IUDs, lecturing on their use globally. He is on the Board of the Israeli Society of Contraception and Sexual Health, Israeli Society of Menopause and the European society of contraception and reproductive health (ESC). Dr. Ber graduated from the Sackler faculty of medicine at the Tel Aviv University.

Valerie Tarico, Ph.D. – Dr. Tarico is deeply involved in reproductive rights and improving access to top tier contraceptives. She serves on the Board of Advocates for Youth, a D.C. based nonprofit with programs related to reproductive health and serves on Planned Parenthood‘s Board of Advocates. Her articles appear on sites including the Huffington Post and the Institute for Ethics and Emerging Technologies.

IUB, SCu300A MINI, SCu300B MIDI, SCu300C MAXI, OCON and the OCON and IUB logos are trademarks of OCON Medical Ltd.
SPHERA is a registered trademark of OCON Medical Ltd.
OCON products are not yet approved for sale in the United States. IUB SCu300C MAXI: CE mark pending.